Bioness completes foot drop study enrolment phase

9 October 2011 (Last Updated October 9th, 2011 18:30)

Bioness has completed the initial enrolment phase of the FASTEST study to further examine the affect of its Ness L300 wireless neurostimulation technology on individuals with foot drop.

Bioness has completed the initial enrolment phase of the FASTEST study to further examine the affect of its Ness L300 wireless neurostimulation technology on individuals with foot drop.

The Ness L300 provides an electrical stimulus to the muscles of the lower leg in order to help lift the foot up while walking.

More than 170 people have been enrolled on the study, which hopes to demonstrate the superiority of the Ness L300 Foot Drop System over standard ankle-foot orthosis therapy.

Patients will receive either the Ness L300 or AFO rehabilitation therapies. They will be monitored for six months and evaluated based on gait function, stroke-specific quality of life and safety.